|
BE637271A
(OSRAM)
|
1963-04-04 |
1900-01-01 |
|
|
|
NL128365C
(OSRAM)
|
1963-11-05 |
|
|
|
|
US3449427A
(en)
|
1965-06-03 |
1969-06-10 |
Smithkline Corp |
Aminocyclopropane derivatives of 5h-dibenzo(a,d)cycloheptenes
|
|
US3697506A
(en)
|
1970-08-07 |
1972-10-10 |
Pfizer |
Crystalline alkali metal salts of {60 -carboxybenzylpenicillin and process therefor
|
|
US3686335A
(en)
|
1970-12-21 |
1972-08-22 |
Smith Kline French Lab |
5-vinyl-5h-di benzo(a,d)cycloheptenes
|
|
US4432987A
(en)
|
1982-04-23 |
1984-02-21 |
Pfizer Inc. |
Crystalline benzenesulfonate salts of sultamicillin
|
|
US4547505A
(en)
|
1983-03-25 |
1985-10-15 |
Degussa Aktiengesellschaft |
N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
|
|
CS244821B2
(en)
|
1983-06-16 |
1986-08-14 |
Boehringer Ingelheim Ltd |
Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas
|
|
DE3418167A1
(de)
|
1984-05-16 |
1985-11-21 |
Bayer Ag, 5090 Leverkusen |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen heteroaryloxyacetamiden
|
|
DE3600288A1
(de)
|
1986-01-08 |
1987-07-16 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonylharnstoff-derivaten
|
|
DE3618004A1
(de)
|
1986-05-28 |
1987-12-03 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonyliso(thio)-harnstoff-derivaten
|
|
EP0507863A4
(en)
|
1989-12-28 |
1993-07-07 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
|
DE69013131T2
(de)
|
1989-12-29 |
1995-05-24 |
Banyu Pharma Co Ltd |
2-(2-Cyclopropylpyrrolidin-4-ylthio)carbapenemderivate.
|
|
IL102909A0
(en)
|
1991-08-22 |
1993-01-31 |
Monsanto Co |
Safening herbicidal pyarazolylsulfonylureas
|
|
DE4131139A1
(de)
|
1991-09-19 |
1993-03-25 |
Bayer Ag |
Verfahren zur herstellung von 1-fluor-cyclopropan-1-carbonsaeure
|
|
AU694419B2
(en)
|
1993-03-12 |
1998-07-23 |
Zoetis P&U Llc |
Crystalline ceftiofur free acid
|
|
AU4368996A
(en)
|
1994-11-23 |
1996-06-17 |
Neurogen Corporation |
Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
|
|
US5604253A
(en)
|
1995-05-22 |
1997-02-18 |
Merck Frosst Canada, Inc. |
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
|
|
US5859246A
(en)
|
1997-01-30 |
1999-01-12 |
Neurogen Corporation |
1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
|
|
JP3476203B2
(ja)
|
1997-02-24 |
2003-12-10 |
ザイモジュネティックス インコーポレイテッド |
カルシトニン擬似体
|
|
US6160134A
(en)
|
1997-12-24 |
2000-12-12 |
Bristol-Myers Squibb Co. |
Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
|
|
WO1999037304A1
(en)
|
1998-01-27 |
1999-07-29 |
Aventis Pharmaceuticals Products Inc. |
SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
|
|
US6268367B1
(en)
|
1998-02-23 |
2001-07-31 |
Zymogenetics, Inc. |
Piperazine derivatives for treating bone deficit conditions
|
|
EP1090919A4
(en)
|
1998-06-26 |
2002-05-22 |
Chugai Pharmaceutical Co Ltd |
L-ALPHA-AMINOADIPIC ACID DERIVATIVE IN FINE POWDER, ORAL SOLID PREPARATIONS CONTAINING SAID DERIVATIVE AND BULK POWDER PROCESSING PROCESS
|
|
US6284761B1
(en)
|
1999-01-08 |
2001-09-04 |
Neurogen Corporation |
1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands
|
|
JP2002534421A
(ja)
|
1999-01-08 |
2002-10-15 |
ニューロゲン コーポレイション |
１−フェニル−４−（１−［２−アリール］シクロプロピル）メチルピペラジン：ドーパミン受容体リガンド
|
|
US6936602B1
(en)
|
1999-06-16 |
2005-08-30 |
Takeda Chemical Industries, Ltd. |
Benzazepine derivatives, process for the preparation of the same and uses thereof
|
|
AU7715300A
(en)
|
1999-09-27 |
2001-04-30 |
Merck & Co., Inc. |
Method of preventing osteoporosis
|
|
AU2930501A
(en)
|
2000-01-07 |
2001-07-24 |
Transform Pharmaceuticals, Inc. |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
US6521619B2
(en)
|
2000-06-29 |
2003-02-18 |
Icos Corporation |
Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
|
|
AU6872401A
(en)
|
2000-06-29 |
2002-01-14 |
Abbott Lab |
Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
|
EP1301484A2
(en)
|
2000-07-20 |
2003-04-16 |
Neurogen Corporation |
Capsaicin receptor ligands
|
|
KR20030062447A
(ko)
|
2000-12-25 |
2003-07-25 |
아지노모토 가부시키가이샤 |
광학 활성 할로하이드린 화합물의 제조방법
|
|
DE60210944T3
(de)
|
2001-02-23 |
2015-07-23 |
Merck Sharp & Dohme Corp. |
N-substituierte nichtaryl-heterocyclische nmda/nr2b antagonisten
|
|
JP2005502623A
(ja)
|
2001-07-02 |
2005-01-27 |
ノボ ノルディスク アクティーゼルスカブ |
置換ピペラジンおよびジアゼパン
|
|
WO2003014110A1
(en)
|
2001-08-08 |
2003-02-20 |
Takeda Chemical Industries, Ltd. |
Benzazepine derivative, process for producing the same, and use
|
|
US7145002B2
(en)
|
2001-09-26 |
2006-12-05 |
Merck & Co. Inc. |
Crystalline forms of carbapenem antibiotics and methods of preparation
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US6861432B2
(en)
|
2001-11-23 |
2005-03-01 |
Schering Aktiengesellschaft |
Piperazine derivatives that destabilize androgen receptors
|
|
WO2003080601A1
(en)
|
2002-03-22 |
2003-10-02 |
Lg Life Sciences Ltd. |
New crystalline forms of (2s)-n-5-[amino(imino)methyl]-2-thienylmethyl-1-(2r)-2-[(carboxymethyl)amino]-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
|
|
AU2003236686A1
(en)
|
2002-06-07 |
2003-12-22 |
Altana Pharma Ag |
4,5-dihydro-imidazo(4,5,1-j) quinolin-6-ones as parp inhibitors
|
|
US20040209858A1
(en)
|
2002-10-22 |
2004-10-21 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
US20040077618A1
(en)
|
2002-10-22 |
2004-04-22 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
AU2003284402A1
(en)
|
2002-11-15 |
2004-06-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Antagonist to melanin-concentrating hormone receptor
|
|
ES2298627T3
(es)
|
2002-12-13 |
2008-05-16 |
Smithkline Beecham Corporation |
Compuestos de ciclopropilo como antagonistas de ccr5.
|
|
ATE402165T1
(de)
|
2003-04-23 |
2008-08-15 |
Glaxo Group Ltd |
Piperazin derivate und ihre verwendung für die behandlung von neurologischen und psychiatrischen krankheiten.
|
|
WO2004098518A2
(en)
|
2003-05-01 |
2004-11-18 |
Bristol-Myers Squibb Company |
Pyrazole-amide compounds useful as kinase inhibitors
|
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
|
CA2549660A1
(en)
|
2003-12-15 |
2005-06-30 |
Japan Tobacco Inc. |
Cyclopropane compounds and pharmaceutical use thereof
|
|
BRPI0418939A
(pt)
|
2004-07-06 |
2008-04-08 |
Xenon Pharmaceuticals Inc |
derivados de nicotinamida e sua utilização como agentes terapêuticos
|
|
TW200621760A
(en)
|
2004-09-09 |
2006-07-01 |
Mitsubishi Pharma Corp |
2-morpholino-4-pyrimidone compound
|
|
DE602005026546D1
(de)
|
2004-09-29 |
2011-04-07 |
Mitsubishi Tanabe Pharma Corp |
Der tau-proteinkinase-1
|
|
SI1802307T1
(sl)
|
2004-10-15 |
2008-08-31 |
Glaxo Group Ltd |
Derivati pirolidina kot ligandi histaminskih receptorjev
|
|
CN101128435A
(zh)
|
2004-12-27 |
2008-02-20 |
阿斯利康(瑞典)有限公司 |
作为代谢型谷氨酸受体激动剂用于治疗神经病学及精神病学病症的吡唑酮化合物
|
|
CA2595882A1
(en)
|
2005-01-26 |
2006-08-03 |
Pharmacia & Upjohn Company Llc |
Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
|
|
ATE517867T1
(de)
|
2005-02-15 |
2011-08-15 |
Glaxo Group Ltd |
Verbindungen, die den glutamatrezeptor verstärken und anwendungen davon in der medizin
|
|
TWI385152B
(zh)
|
2005-02-17 |
2013-02-11 |
Astellas Pharma Inc |
Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivatives (I)
|
|
EP1874780A1
(en)
|
2005-03-25 |
2008-01-09 |
Pharmacia & Upjohn Company LLC |
4-piperazinylthieno[2,3-d]pyrimidine compounds as platelet aggregation inhibitors
|
|
JP2008534571A
(ja)
|
2005-03-28 |
2008-08-28 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
血小板凝集阻害物質としての４−ピペラジニルチエノ［２，３−ｄ］ピリミジン化合物
|
|
JP2008534573A
(ja)
|
2005-03-28 |
2008-08-28 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
血小板凝集阻害剤としての４−ピペラジノチエノ［２，３−ｄ］ピリミジン化合物
|
|
EP1896483A2
(en)
|
2005-03-28 |
2008-03-12 |
Pharmacia & Upjohn Company LLC |
4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
WO2007011623A1
(en)
|
2005-07-15 |
2007-01-25 |
Schering Corporation |
Quinazoline derivatives useful in cancer treatment
|
|
TW200740779A
(en)
|
2005-07-22 |
2007-11-01 |
Mitsubishi Pharma Corp |
Intermediate compound for synthesizing pharmaceutical agent and production method thereof
|
|
CA2606004A1
(en)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
ME01181B
(me)
*
|
2005-09-16 |
2013-03-20 |
Janssen Pharmaceutica Nv |
Ciklopropil amini kao modulatori histaminskog h3 receptora
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
JP5185822B2
(ja)
|
2005-10-31 |
2013-04-17 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
シクロプロピル−アミド誘導体の製造方法
|
|
CA2633653A1
(en)
|
2005-12-21 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
WO2007076140A2
(en)
|
2005-12-23 |
2007-07-05 |
University Of Cincinnati |
Treatment methods employing histamine h3 receptor antagonists, including betahistine
|
|
RU2008132966A
(ru)
|
2006-01-13 |
2010-02-20 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Производные циклогексилпиперазинилметанона и их применение в качестве модуляторов гистамин н3 рецептора
|
|
CN101384581B
(zh)
|
2006-02-17 |
2013-09-18 |
弗·哈夫曼-拉罗切有限公司 |
作为5ht2/d3调节剂的苯甲酰基-哌啶衍生物
|
|
MX2008011133A
(es)
|
2006-03-01 |
2008-12-18 |
Cementech Pty Ltd |
Matriz para elementos de albañileria y metodo de fabricacion de la misma.
|
|
JP2009132621A
(ja)
|
2006-03-13 |
2009-06-18 |
Ajinomoto Co Inc |
シクロプロピルアミド化合物の製造方法
|
|
JP2009530390A
(ja)
|
2006-03-23 |
2009-08-27 |
アムゲン インコーポレイティッド |
１−フェニルスルホニル−ジアザ複素環アミド化合物およびヒドロキシステロイドデヒドロゲナーゼ調節因子としてのその使用
|
|
EP2039689A4
(en)
|
2006-05-26 |
2011-12-28 |
Kaneka Corp |
PROCESS FOR PREPARING OPTICALLY ACTIVE 3-AMINO-2-HYDROXYPROPIONIC ACID CYCLOPROPYLAMID DERIVATIVES AND SALTS THEREOF
|
|
US9108948B2
(en)
|
2006-06-23 |
2015-08-18 |
Abbvie Inc. |
Cyclopropyl amine derivatives
|
|
MX2008016343A
(es)
|
2006-06-23 |
2009-01-19 |
Abbott Lab |
Derivados ciclopropil amina como moduladores del receptro de histamina h3.
|
|
US20100016293A1
(en)
|
2006-07-03 |
2010-01-21 |
Rogier Adriaan Smits |
Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
|
|
US20090247499A1
(en)
|
2006-08-21 |
2009-10-01 |
Fletcher Joan M |
Sulfonylated piperazines as cannabinoid-1 receptor modulators
|
|
TW200828371A
(en)
|
2006-09-21 |
2008-07-01 |
Matsushita Electric Industrial Co Ltd |
Chip-type filter
|
|
DE102006056526A1
(de)
|
2006-11-30 |
2008-06-05 |
Archimica Gmbh |
Verfahren zur stereoselektiven Synthese von chiralen Epoxiden durch ADH-Reduktion von alpha-Abgangsgruppen-substituierten Ketonen und Cyclisierung
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
WO2008147864A2
(en)
*
|
2007-05-22 |
2008-12-04 |
Xenon Pharmaceuticals Inc. |
Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
|
|
US8030495B2
(en)
|
2007-05-23 |
2011-10-04 |
Coleman Paul J |
Cyclopropyl pyrrolidine orexin receptor antagonists
|
|
ES2350511T3
(es)
*
|
2007-06-11 |
2011-01-24 |
F. Hoffmann-La Roche Ag |
Derivados ciclohexilo.
|
|
ES2442926T3
(es)
*
|
2007-08-22 |
2014-02-14 |
Astrazeneca Ab |
Derivados de ciclopropilamida `978
|
|
JP5362729B2
(ja)
|
2007-10-04 |
2013-12-11 |
エフ．ホフマン−ラ ロシュ アーゲー |
シクロプロピルアリールアミド誘導体及びその使用
|
|
PE20091313A1
(es)
|
2008-01-15 |
2009-09-03 |
Lilly Co Eli |
(r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina
|
|
DE102008049371A1
(de)
|
2008-03-06 |
2009-09-10 |
Mühlbauer Ag |
Einrichtung mit einem RFID-Transponder in einem elektrisch leitfähigen Gegenstand und Herstellungsverfahren hierfür
|
|
US8691804B2
(en)
|
2008-05-08 |
2014-04-08 |
Evotec Ag |
Azetidines and cyclobutanes as histamine H3 receptor antagonists
|
|
CN102137836B
(zh)
|
2008-07-28 |
2015-08-26 |
赛丹思科大学 |
用于治疗代谢疾病的化合物
|
|
CN101462980B
(zh)
|
2009-01-05 |
2013-01-09 |
扬州天辰精细化工有限公司 |
2，6—二氟苯甲酰胺的工业化生产方法
|
|
TW201039825A
(en)
|
2009-02-20 |
2010-11-16 |
Astrazeneca Ab |
Cyclopropyl amide derivatives 983
|
|
NZ602110A
(en)
|
2010-02-18 |
2014-09-26 |
Astrazeneca Ab |
Processes for making cyclopropyl amide derivatives and intermediates associated therewith
|
|
AR080203A1
(es)
*
|
2010-02-18 |
2012-03-21 |
Astrazeneca Ab |
Formas solidas que comprenden una ciclopropilamida
|